A protein already targeted by FDA-approved cancer drugs may also help the body fight influenza, according to new research from The Jackson Laboratory (JAX). Published in Cell Reports, the study found ...
The US FDA’s vaccine advisors have recommended that three new influenza strains be included in next winter’s influenza vaccine, aiming in part to tamp down illness caused by subclade K, a mutated form ...
Moderna said it met with the FDA on Tuesday to discuss the vaccine and afterward, the U.S. regulator accepted a revised application seeking full approval of the shot for adults ages 50 to 64, and ...
Incentives to bring vaccines to market are shrinking. Drugmakers are scaling back research investments and cutting jobs.
With the reversal from the FDA, Moderna said it is aiming to make the vaccine available for the 2026-27 flu season.
The Food and Drug Administration's embattled vaccine chief, Dr. Vinay Prasad, is once again leaving the agency — the second ...
The Bulwark on MSNOpinion
FDA reverses course, agrees to review Moderna’s flu vaccine
Andrew Egger and Jonathan Cohn give their takes on the stunning back-and-forth at the FDA over Moderna’s new mRNA flu vaccine ...
The FDA is slated to make a decision on the flu shot on Aug. 5, which will allow Moderna to make the vaccine available for the upcoming influenza season.
Add Yahoo as a preferred source to see more of our stories on Google. Moderna met with FDA officials after the agency initially rejected its application for a new mRNA flu vaccine. - Sarah ...
The US Food and Drug Administration (FDA) vaccine advisory committee has approved updated influenza vaccine strains for the upcoming flu season, while emphasizing the need for vaccines that offer ...
The Food and Drug Administration reversed course on Wednesday and agreed to formally review Moderna’s new flu vaccine that uses mRNA technology, the company announced in a news release. Earlier this ...
Add Yahoo as a preferred source to see more of our stories on Google. The U.S. Food and Drug Administration will review Moderna's mRNA 1010 flu vaccine for older adults, which could make it available ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results